Zobrazeno 1 - 10
of 2 932
pro vyhledávání: '"Metronomic Chemotherapy"'
Autor:
Jiaxuan Liu, Maiyue He, Mingxia Jiang, Shihan Zhou, Mengqi Zhang, Yiqun Li, Shanshan Chen, Ruigang Cai, Hongnan Mo, Bo Lan, Fei Ma, Binghe Xu, Qiao Li
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Exploration of novel combination mode of pyrotinib and chemotherapy for heavily pretreated HER2-positive metastatic breast cancer (MBC) and how to balance survival benefits and compliance are still urgent problems in clinical prac
Externí odkaz:
https://doaj.org/article/7f027f026be5409096c94cd702688cf3
Autor:
Sewanti Limaye, Mohan Menon, Shambhavi Singh, Pritam Kataria, Aditya V. Shreenivas, Rajan Datar, Darshana Patil, Prashant Kumar, Niyati Shah, Hardik Sheth, Suku Sneha, Chetan Madre, Ruturaj Deshpande, Narayan K. Menon, Prasad Dandekar, Vijay Haribhakti
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Vol 7, Iss 3, Pp 171-177 (2024)
Externí odkaz:
https://doaj.org/article/ce0a692af1a740f8a75c22fdae69b2d7
Autor:
Yulia V. Dinikina, Olga G. Zheludkova, Marina V. Ryzhova, Liudmila V. Olhova, Denis Yu. Korneev, Margarita B. Belogurova
Publikováno v:
Современная онкология, Vol 26, Iss 2, Pp 238-246 (2024)
Metronomic chemotherapy (MCT) is a promising direction of anticancer therapy, as well as in pediatric oncology, and its administration in patients with refractory and recurrent tumors of the central nervous system becomes increasingly relevant. Being
Externí odkaz:
https://doaj.org/article/992c57aca07d4307a2aa891417cd209d
Autor:
Yamila Sanchez, Mariana Abigail Vasquez Callejas, Noelia Victoria Miret, Gabino Rolandelli, Catalina Costas, Andrea Silvana Randi, Alejandro Español
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 5, Iss 2, Pp 278-295 (2024)
Aim: Triple negative breast cancer (TNBC) is usually treated with high doses of paclitaxel, whose effectiveness may be modulated by the action of environmental contaminants such as hexachlorobenzene. High doses of paclitaxel cause adverse effects suc
Externí odkaz:
https://doaj.org/article/6fca8016091244d5acb3ac7f64ae92fb
Publikováno v:
Breast, Vol 78, Iss , Pp 103795- (2024)
Background: Chemotherapy is commonly used in metastatic breast cancer (MBC) to prolong life and improve quality of life (QoL). The optimal dosing and sequencing beyond the second line of treatment are unknown and pose a risk of overtreatment. Continu
Externí odkaz:
https://doaj.org/article/51f3090707e341458051295855af6b19
Autor:
Huining You, Peipei Zhao, Xue Zhao, Qiaowei Zheng, Wenbing Ma, Kai Cheng, Min Li, Jianrong Kou, Weiyi Feng
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundMore research is needed to solidify the basis for reasonable metronomic chemotherapy regimens due to the inconsistent clinical outcomes from studies on metronomic chemotherapy with antineoplastic agents, along with signs of a nonlinear dose
Externí odkaz:
https://doaj.org/article/a20d99fad4ff4bd0ba7beb25a73aee98
Publikováno v:
Frontiers in Veterinary Science, Vol 11 (2024)
Veterinary oncology has experienced significant evolution over the last few decades, with chemotherapy being currently applied to several neoplasms with therapeutic success. Traditionally, chemotherapy protocols are based on classic cytostatic drugs
Externí odkaz:
https://doaj.org/article/be35bc0411734150a4d71e161213fca7
Autor:
Laura Orlando, Evaristo Maiello, Michele Orditura, Anna Diana, Giuliano Antoniol, Maria Grazia Morritti, Michele Aieta, Mariangela Ciccarese, Salvatore Pisconti, Roberto Bordonaro, Antonio Russo, Antonio Febbraro, Paola Schiavone, Annamaria Quaranta, Chiara Caliolo, Dario Loparco, Margherita Cinefra, Giuseppe Colucci, Saverio Cinieri
Publikováno v:
Breast, Vol 75, Iss , Pp 103725- (2024)
Background: Optimizing chemotherapy to achieve disease and symptoms control is a noteworthy purpose in advanced breast cancer (ABC). We reported the activity and quality of life of a phase II study, comparing metronomic regimen with standard schedule
Externí odkaz:
https://doaj.org/article/f8bb73659cf247ab88a3fb4350dd4d67
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 12 (2024)
Metronomic chemotherapy (MCT), characterized by the continuous administration of chemotherapeutics at a lower dose without prolonged drug-free periods, has garnered significant attention over the last 2 decades. Extensive evidence from both pre-clini
Externí odkaz:
https://doaj.org/article/73f4982b4c4148ce8c01a2e210ab940e
Autor:
Yulia V. Dinikina, Olga G. Zheludkova, Margarita B. Belogurova, Dmitry M. Spelnikov, Nikolai N. Osipov, Irina L. Nikitina
Publikováno v:
Современная онкология, Vol 25, Iss 4, Pp 454-465 (2023)
Medulloblastoma (MB) is the most common malignant tumor of the central nervous system in pediatric patients. Despite the complex anticancer therapy approach, refractory and relapsing forms of the disease remain fatal in most cases and account for app
Externí odkaz:
https://doaj.org/article/d50cd51594df41fab19a9c9c1c3f8c44